In May 2021, the Centers for Medicare and Medicaid Services (CMS) Quality Measures Voting Members unanimously recommended the addition of colorectal cancer (CRC) screening to the CMS Medicaid Adult Core Set of Quality Measures for adoption in 2022. However, CMS has the latitude to reject recommendations
from the Voting Members. The proposed CMS Medicaid CRC screening quality measure should be supported because it is actionable, has alignment with other metrics, is appropriate, is feasible, and will promote equity for all people insured through CMS.
Trending
- SAGA Diagnostics® Launches Ultrasensitive Pathlight™ MRD Test in Colorectal Cancer (Business Wire)
- Task force updates ERCP quality metrics (GI & Hepatology News)
- New simulator mimics real tissue for safer endoscopic cancer surgery training (Medical Xpress)
- 5 GI leaders on what’s changing in colonoscopy (Becker’s GI & Endoscopy)
- Scientists create a luminous pill with biosensors meant to replace colonoscopies (Earth.com)
- FUJIFILM 800 Series Duodenoscopes Now Compatible with CE Mark Approved ULTRA GI Cycle (Fujifilm)
- Private Equity’s Healthcare Boom Is Getting More Crowded (MedCity News)
- Nvidia, Eli Lilly to spend $1 billion over five years on joint research lab (Reuters)
